Cost Of Sofia-2-Sars Antibody
Lab Reagents
Human IgG antibody Laboratories manufactures the cost of sofia-2-sars antibody reagents distributed by Genprice. The Cost Of Sofia-2-Sars Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Cost products are available in stock. Specificity: Cost Category: Of Group: Sofia-2-Sars Antibody
Sofia-2-Sars Antibody information
SARS Matrix Antibody |
|||
24320-100ul | SAB | 100ul | EUR 390 |
SARS Envelope Antibody |
|||
24321-100ul | SAB | 100ul | EUR 390 |
SARS Envelope Antibody |
|||
24322-100ul | SAB | 100ul | EUR 390 |
Anti-SARS antibody |
|||
STJ115313 | St John's Laboratory | 100 µl | EUR 277 |
Description: This gene belongs to the class II amino-acyl tRNA family. The encoded enzyme catalyzes the transfer of L-serine to tRNA (Ser) and is related to bacterial and yeast counterparts. Multiple alternatively spliced transcript variants have been described but the biological validity of all variants is unknown. |
anti- SARS antibody |
|||
FNab07609 | FN Test | 100µg | EUR 548.75 |
Description: Antibody raised against SARS |
SARS Conjugated Antibody |
|||
C39139 | SAB | 100ul | EUR 397 |
Anti-SARS antibody |
|||
PAab07609 | Lifescience Market | 100 ug | EUR 386 |
SARS E2 antibody |
|||
10R-1976 | Fitzgerald | 100 ul | EUR 241 |
Description: Mouse monoclonal SARS E2 antibody |
SARS M antibody |
|||
10R-1977 | Fitzgerald | 100 ul | EUR 241 |
Description: Mouse monoclonal SARS M antibody |
SARS Coronavirus antibody |
|||
10C-CR9003M1 | Fitzgerald | 100 ug | EUR 499 |
Description: Mouse monoclonal SARS Coronavirus antibody |
SARS Nucleocapsid antibody |
|||
10R-10470 | Fitzgerald | 100 ug | EUR 435 |
Description: Mouse monoclonal SARS Nucleocapsid antibody |
SARS Nucleocapsid antibody |
|||
10R-10471 | Fitzgerald | 100 ug | EUR 435 |
Description: Mouse monoclonal SARS Nucleocapsid antibody |
Sars/ Rat Sars ELISA Kit |
|||
ELI-41050r | Lifescience Market | 96 Tests | EUR 886 |
Anti-SARS-CoV-2 Antibody (Clone# 6F10) |
|||
A2060-50 | Biovision | 50 µg | EUR 480 |
Anti-SARS-CoV-2 Spike S1 Antibody |
|||
A3000-50 | Biovision | 50 µg | EUR 419 |
SARS-CoV-2 (COVID-19) Spike Antibody |
|||
3525-002mg | ProSci | 0.02 mg | EUR 171.82 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |
SARS-CoV-2 (COVID-19) Spike Antibody |
|||
3525-01mg | ProSci | 0.1 mg | EUR 436.42 |
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6). |